The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 26th 2025
New research confirms hydroxyurea's long-term effectiveness in reducing hospital visits for children with sickle cell anemia, supporting its use as standard treatment.
Despite Increase in COVID-19 Cases Outside China, WHO Says the Virus is Not Yet a Pandemic
February 24th 2020In a press briefing, WHO Director-General Tedros Adhanom, PhD, said the decision to declare a pandemic is based on ongoing assessments of the geographic spread, the virus’s impact on overall society, and the severity of the illnesses.
Read More
Varenicline for Smoking Cessation Not Associated with Increased Cardiovascular Hospitalization
February 24th 2020Smoking cessation medication varenicline does not appear to be associated with an increased risk of cardiovascular or neuropsychiatric hospitalization compared with nicotine replacement therapy.
Read More
First Clinical Trial to Test PrEP, Dapivirine Ring for Safety in Pregnant Women Begins
February 20th 2020The study, called DELIVER: A Phase 3b Safety Study of the Dapivirine Ring and PrEP in Pregnant Women, will complement an ongoing NIH-funded trial of PrEP in adolescents and young women during pregnancy and the first 6 months after birth.
Read More
New Diabetes Drug Combination Induces High Rates of Human Beta Cell Regeneration
February 20th 2020When combining a drug that is known to cause beta cells to proliferate with another drug that is already in widespread use in people with diabetes, it will cause the cells to proliferate at a rate of 5% to 6% per day, according to the study authors.
Read More
Politicians on both sides of the aisle have long been debating key issues in modern health care, including rising drug prices, access to care, and national addiction rates. Despite some agreement on which issues are most pressing, arguments persist in how to address them heading into the 2020 presidential election.
Read More
FDA Approves Topical Arthritis Pain Reliever for Nonprescription Use
February 18th 2020Diclofenac sodium topical gel was first approved by the FDA in 2007 as a prescription drug, and was indicated for the relief of osteoarthritis pain in joints responsive to topical treatment, particularly the joints of the hands, knees, and feet.
Read More
Hydrogel Platform Preserves Medicines, Chemicals for Future Use
February 17th 2020New on-demand approach could aid where the absence of pharmacies, physician offices, or basic refrigeration makes it difficult to access critical medicines, daily use chemicals, and other small-molecule compounds.
Read More
Study Supports Added Use of Tiotropium Bromide for Asthma
February 16th 2020Results from a new retrospective analysis have shown that patients prescribed tiotropium bromide (Spiriva Respimat) inhalation spray 1.25 mcg experienced fewer asthma-related exacerbations when the treatment was added to a combination inhaled corticosteroid and long-acting beta2 agonist (ICS + LABA), compared with patients who received an increased dose of ICS + LABA.
Read More